Tag: RAS GTPase

Home / RAS GTPase

Categories

Sotorasib receives accelerated approval from the FDA for KRAS G12C mutant NSCLC

August 2021: The FDA granted accelerated approval to sotorasib (LumakrasTM, Amgen, Inc.), a RAS GTPase family inhibitor, for adult patients with KRAS G12C mutated locally advanced or metastatic non-sm...
ras-gtpase

Scan the code